Research Article

In vitro REGULATION OF THE EXPRESSION OF THE SARS-CoV-2 RECEPTOR ANGIOTENSIN-CONVERTING ENZYME (ACE2) IN LUNG CANCER CELLS BY NATURAL PRODUCTS

Volume: 22 Number: 2 October 15, 2021
EN TR

In vitro REGULATION OF THE EXPRESSION OF THE SARS-CoV-2 RECEPTOR ANGIOTENSIN-CONVERTING ENZYME (ACE2) IN LUNG CANCER CELLS BY NATURAL PRODUCTS

Abstract

The COVID-19 pandemic continues infecting people causing deaths globally. Although various medicines have been tried to combat with COVID-19, there is no medicine or treatment that has been validated yet. People have been using natural products for centuries against bacterial and viral illnesses. This study aimed to test the effects of the biomolecule oleuropein, whey collected from industrial waste and soaproot extracts obtained from Gypsophila arrostii Guss. var. nebulosa Boiss. & Heldr. and Saponaria officinalis L. on the expression of the human ACE2 gene as SARS-CoV-2 receptor on the A549 adenocarcinoma cell-line by Real-Time Quantitative Polymerase Chain Reaction (qPCR). According to the cytotoxicity tests, G. arrostii var. nebulosa and S. officinalis extract treatments showed a dose dependent cytotoxic effect on the cells. The EC50 values of G. arrostii var. nebulosa and S. officinalis were found to be 54.3 μg/ml and 17.3 μg/ml, respectively. Oleuropein showed moderate cytotoxic effects with the EC50 value over 250 μg/ml. Whey (fermented and non-fermented) did not show any cytotoxic effect at the applied doses. The qPCR results showed that the ACE2 mRNA level decreased by 89.8% and 35.2% due to the fermented and non-fermented whey extracts, respectively. Similarly, G. arrostii var. nebulosa and S. officinalis downregulated ACE2 by 79.8% and 90.1%, respectively. In contrast, oleropein upregulated ACE2 (102.8%). Our results showed that the natural supporting products produced from soaproot extracts and fermented whey can be used against COVID-19 by both cancer patients and people in potential risk groups. 

Keywords

Thanks

We thank Cathy Seither (Texas, USA) for language proof, anonymous referees and editors who helped to improve the manuscript.

References

  1. 1. Almehdar, H.A., El-Fakharany, E.M., Uversky, V.N. & Redwan, E.M. 2015. Disorder in milk proteins: structure, functional disorder, and biocidal potentials of lactoperoxidase. Current Protein & Peptide Science, 16(4): 352-365.
  2. 2. Arslan, I., Celik, A. & Melzig, M.F. 2013. Nebulosides A-B, novel triterpene saponins from under-ground parts of Gypsophila arrostii Guss. var. nebulosa. Bioorganic & Medicinal Chemistry, 21(5): 1279-1283.
  3. 3. Arslan, I. & Cenzano, A.M. 2020. N-triterpene saponins in cancer therapy: A review of mode of action. Revista Brasileira de Farmacognosia, 30(1): 1-6. https://doi.org/10.1007/s43450-020-00033-5
  4. 4. Carrera-González, M.P., Ramírez-Expósito, M.J., Mayas, M.D. & Martínez-Martos, J.M. 2013. Protective role of oleuropein and its metabolite hydroxytyrosol on cancer. Trends in Food Science & Technology, 31(2): 92-99.
  5. 5. Carzaniga, R., Sinclair, L., Fordham-Skelton, A.P., Harris, N. & Croy, R.R.D. 1994. Cellular and subcellular distribution of saporins, type-1 ribosome-inactivating proteins, in soapwort (Saponaria officinalis L.). Planta, 194(4): 461-470.
  6. 6. Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X. & Zhang, L. 2020. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England), 395(10223): 507-513.
  7. 7. Cheng, G., Gao, F., Sun, X., Bi, H. & Zhu, Y. 2016. Paris saponin VII suppresses osteosarcoma cell migration and invasion by inhibiting MMP‑2/9 production via the p38 MAPK signaling pathway. Molecular Medicine Reports, 14(4): 3199-3205.
  8. 8. Davis, P.H. 1970. Flora of Turkey and the east aegean islands. Vol. 3. Edinburgh: University Press, 629 p.

Details

Primary Language

English

Subjects

Structural Biology

Journal Section

Research Article

Publication Date

October 15, 2021

Submission Date

March 12, 2021

Acceptance Date

June 15, 2021

Published in Issue

Year 1970 Volume: 22 Number: 2

APA
Hürkan, K., Arslan, Ş., Atalar, M. N., Aydın, A., Demirtaş, İ., Mutlu, D., Tabar, B., & Alma, M. H. (2021). In vitro REGULATION OF THE EXPRESSION OF THE SARS-CoV-2 RECEPTOR ANGIOTENSIN-CONVERTING ENZYME (ACE2) IN LUNG CANCER CELLS BY NATURAL PRODUCTS. Trakya University Journal of Natural Sciences, 22(2), 155-161. https://doi.org/10.23902/trkjnat.896013
AMA
1.Hürkan K, Arslan Ş, Atalar MN, et al. In vitro REGULATION OF THE EXPRESSION OF THE SARS-CoV-2 RECEPTOR ANGIOTENSIN-CONVERTING ENZYME (ACE2) IN LUNG CANCER CELLS BY NATURAL PRODUCTS. Trakya Univ J Nat Sci. 2021;22(2):155-161. doi:10.23902/trkjnat.896013
Chicago
Hürkan, Kaan, Şevki Arslan, Mehmet Nuri Atalar, et al. 2021. “In Vitro REGULATION OF THE EXPRESSION OF THE SARS-CoV-2 RECEPTOR ANGIOTENSIN-CONVERTING ENZYME (ACE2) IN LUNG CANCER CELLS BY NATURAL PRODUCTS”. Trakya University Journal of Natural Sciences 22 (2): 155-61. https://doi.org/10.23902/trkjnat.896013.
EndNote
Hürkan K, Arslan Ş, Atalar MN, Aydın A, Demirtaş İ, Mutlu D, Tabar B, Alma MH (October 1, 2021) In vitro REGULATION OF THE EXPRESSION OF THE SARS-CoV-2 RECEPTOR ANGIOTENSIN-CONVERTING ENZYME (ACE2) IN LUNG CANCER CELLS BY NATURAL PRODUCTS. Trakya University Journal of Natural Sciences 22 2 155–161.
IEEE
[1]K. Hürkan et al., “In vitro REGULATION OF THE EXPRESSION OF THE SARS-CoV-2 RECEPTOR ANGIOTENSIN-CONVERTING ENZYME (ACE2) IN LUNG CANCER CELLS BY NATURAL PRODUCTS”, Trakya Univ J Nat Sci, vol. 22, no. 2, pp. 155–161, Oct. 2021, doi: 10.23902/trkjnat.896013.
ISNAD
Hürkan, Kaan - Arslan, Şevki - Atalar, Mehmet Nuri - Aydın, Adnan - Demirtaş, İbrahim - Mutlu, Doğukan - Tabar, Bahattin - Alma, Mehmet Hakkı. “In Vitro REGULATION OF THE EXPRESSION OF THE SARS-CoV-2 RECEPTOR ANGIOTENSIN-CONVERTING ENZYME (ACE2) IN LUNG CANCER CELLS BY NATURAL PRODUCTS”. Trakya University Journal of Natural Sciences 22/2 (October 1, 2021): 155-161. https://doi.org/10.23902/trkjnat.896013.
JAMA
1.Hürkan K, Arslan Ş, Atalar MN, Aydın A, Demirtaş İ, Mutlu D, Tabar B, Alma MH. In vitro REGULATION OF THE EXPRESSION OF THE SARS-CoV-2 RECEPTOR ANGIOTENSIN-CONVERTING ENZYME (ACE2) IN LUNG CANCER CELLS BY NATURAL PRODUCTS. Trakya Univ J Nat Sci. 2021;22:155–161.
MLA
Hürkan, Kaan, et al. “In Vitro REGULATION OF THE EXPRESSION OF THE SARS-CoV-2 RECEPTOR ANGIOTENSIN-CONVERTING ENZYME (ACE2) IN LUNG CANCER CELLS BY NATURAL PRODUCTS”. Trakya University Journal of Natural Sciences, vol. 22, no. 2, Oct. 2021, pp. 155-61, doi:10.23902/trkjnat.896013.
Vancouver
1.Kaan Hürkan, Şevki Arslan, Mehmet Nuri Atalar, Adnan Aydın, İbrahim Demirtaş, Doğukan Mutlu, Bahattin Tabar, Mehmet Hakkı Alma. In vitro REGULATION OF THE EXPRESSION OF THE SARS-CoV-2 RECEPTOR ANGIOTENSIN-CONVERTING ENZYME (ACE2) IN LUNG CANCER CELLS BY NATURAL PRODUCTS. Trakya Univ J Nat Sci. 2021 Oct. 1;22(2):155-61. doi:10.23902/trkjnat.896013